{"id":2364,"date":"2019-10-05T20:19:55","date_gmt":"2019-10-05T18:19:55","guid":{"rendered":"https:\/\/idibell.cat\/?page_id=2364"},"modified":"2024-06-19T14:38:10","modified_gmt":"2024-06-19T12:38:10","slug":"transformation-and-metastasis-2","status":"publish","type":"page","link":"https:\/\/idibell.cat\/en\/research\/cancer-area\/molecular-mechanisms-and-experimental-therapy-in-oncology-program-oncobell\/transformation-and-metastasis-2\/","title":{"rendered":"Transformation and Metastasis"},"content":{"rendered":"\n
This group’s research aims to identify new therapeutic targets for cancer which can be directly translated into effective prevention or treatment strategies. Its aim is to understand the signalling pathways involved in the epithelial stem cell fate and homeostasis, their alterations during cancer and metastasis, and the interactions between tumour cells and their microenvironment.<\/p>\n
The experience of the group’s members includes mammary-gland development, breast cancer and immunology.<\/p>\n
\u00a0The group has a multidisciplinary focus and uses genetically modified mice models, patient-derived xenografts, clinical samples, organoids and 3D cultures, and molecular and cellular biology techniques to translate basic research into relevant clinical results.<\/p>\n
<\/p>\n
The group has received uninterrupted competitive funding from public and private bodies, both nationally and internationally, with a total of 17 grants. Funding agencies include the following: MINECO, ISCIII, AECC, Mutua Madrile\u00f1a Foundation, Marat\u00f3 de TV3, as well as the most prestigious international associations (Concern Foundation (USA), Susan G. Komen Foundation (USA)). It recently received an ERC Consolidator Grant from the European Union, awarded to Dr Gonz\u00e1lez Su\u00e1rez.<\/p>\n
The group has also signed contacts with the industry and coordinates initial-phase clinical trials.<\/p>\n
<\/p>\nReferencia: 682935
\nT\u00edtulo: PLEIO-RANK: Pleiotropic treatment of cancer: RANK inhibitors targeting cancer stem cells and immunity
\nFinanciador: ERC – H2020
\nAgradecimiento: European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program\n
<\/p>\nReferencia: SLT006\/17\/00122
\nTipo: “CONTRACTES D’INCORPORACI\u00d3 DE CIENT\u00cdFICS I TECN\u00d2LEGS ALS GRUPS DE RECERCA”
\nFinanciador: DEPARTAMENT DE SALUT
\nAgradecimiento: Departament de Salut de la Generalitat de Catalunya mitjan\u00e7ant l’Acci\u00f3 instrumental d’incorporaci\u00f3 (PERIS).\n
<\/p>\n
<\/p>\nReferencia: BES-2015-071675
\nTipo: “AYUDAS PARA CONTRATOS PREDOCTORALES PARA LA FORMACI\u00d3N DE DOCTORES 2015”
\nFinanciador: Ministerio de Ciencia, Innovaci\u00f3n y Universidades
\nAgradecimiento: Ministerio de Ciencia, Innovaci\u00f3n y Universidades, perteneciente a la Agencia Estatal de Investigaci\u00f3n (AEI). Cofinanciado por el Fondo Social Europeo. FSE invierte en tu futuro\n
<\/p>\n
<\/p>\n
<\/p>\nReferencia: PRE2018-086522
\nTipo: “AYUDAS PARA CONTRATOS PREDOCTORALES PARA LA FORMACI\u00d3N DE DOCTORES 2018”
\nFinanciador: Ministerio de Ciencia, Innovaci\u00f3n y Universidades
\nAgradecimiento: Ministerio de Ciencia, Innovaci\u00f3n y Universidades, perteneciente a la Agencia Estatal de Investigaci\u00f3n (AEI). Cofinanciado por el Fondo Social Europeo. FSE invierte en tu futuro\n
<\/p>\n
<\/p>\n
<\/p>\nReferencia: IJCI-2017-31564
\nTipo: “AYUDAS JUAN DE LA CIERVA – INCORPORACION 2017”
\nFinanciador: Ministerio de Ciencia, Innovaci\u00f3n y Universidades
\nAgradecimiento: Ministerio de Ciencia, Innovaci\u00f3n y Universidades, perteneciente a la Agencia Estatal de Investigaci\u00f3n (AEI).\n
<\/p>\nReferencia: FJCI-2017-31565
\nTipo: “AYUDAS JUAN DE LA CIERVA – FORMACION 2017”
\nFinanciador: Ministerio de Ciencia, Innovaci\u00f3n y Universidades
\nAgradecimiento: Ministerio de Ciencia, Innovaci\u00f3n y Universidades, perteneciente a la Agencia Estatal de Investigaci\u00f3n (AEI).
\n\nReferencia: IDEAS19093GONZ
\nT\u00edtulo: RANK, instead of RANKL, as a new therapeutic target in Triple Negative Breast Cancer
\nFinanciador: Fundaci\u00f3n Cient\u00edfica de la AECC
\nAgradecimiento: Fundaci\u00f3n Cient\u00edfica de la Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer\n
<\/p>\nSAF2017-86117-R. New insights in RANK signaling pathway: from biology to treatment
\nPI: Gonz\u00e1lez-Su\u00e1rez, Eva
\nMinisterio de Ciencia, Innovaci\u00f3n y Universidades, perteneciente a la Agencia Estatal de Investigaci\u00f3n (AEI).\n
Cofinanciado por el Fondo Europeo de Desarrollo Regional. FEDER, una manera de hacer Europa. Promover el desarrollo tecnol\u00f3gico, la innovaci\u00f3n y una investigaci\u00f3n de calidad.<\/p>\n
<\/p>\n
<\/p>\n\t\t\t\t\n
Transformation and metastasis Summary This group’s research aims to identify new therapeutic targets for cancer which can be directly translated into effective prevention or treatment strategies. Its aim is to understand the signalling pathways involved in the epithelial stem cell fate and homeostasis, their alterations during cancer and metastasis, and the interactions between tumour cells […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":448,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"class_list":["post-2364","page","type-page","status-publish","hentry"],"publishpress_future_action":{"enabled":false,"date":"2025-01-25 09:43:12","action":"change-status","newStatus":"draft","terms":[],"taxonomy":""},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/pages\/2364","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/comments?post=2364"}],"version-history":[{"count":8,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/pages\/2364\/revisions"}],"predecessor-version":[{"id":24323,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/pages\/2364\/revisions\/24323"}],"up":[{"embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/pages\/448"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/media?parent=2364"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}